Senators Tackle Currency, Trade Issues in New Bill
Washington, DC – U.S. Senators Chuck Grassley (R-Iowa) and Max Baucus (D-Mont.), Chairman and Ranking Member of the Senate Finance Committee, today introduced legislation aimed at resolving contentious currency and trade enforcement issues between the U.S. and other countries worldwide. The U.S. Trade Enhancement Act of 2006 would give the U.S. government new rules and […]
Grassley Seeks Full Red Cross Review of Governance, Whistleblower Concerns
M E M O R A N D U M To: Reporters and EditorsRe: Allegations from Red Cross volunteersDa: Friday, March 24, 2006 Today’s news reports described allegations raised by Red Cross volunteers of problemsmanaging resources and volunteers after Hurricane Katrina, even including some possible criminalmisconduct. Sen. Chuck Grassley, chairman of the Committee on Finance, […]
Grassley Discouraged by Prospects for WTO Talks After Brazil Trip
M E M O R A N D U M To: Reporters and EditorsRe: Grassley statement on Brazil/WTODa: Thursday, March 23, 2006 Sen. Chuck Grassley, chairman of the U.S. Senate Finance Committee, which has jurisdiction overinternational trade, made the following statement after leading an official delegation of senators andcongressmen to Brazil. The delegation met with […]
Grassley: Report Shows Computer Security of Medicare, Medicaid Data is Lacking
M E M O R A N D U M To: Reporters and EditorsRe: GAO report on information security at HHS, CMSDa: Thursday, March 23, 2006 Sen. Chuck Grassley, chairman of the Committee on Finance, with jurisdiction overMedicare and Medicaid, asked the Government Accountability Office to review information securityat the Department of Health and Human […]
Grassley Works to Implement New Incentives for States to Fight Medicaid Fraud
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, is urgingthe federal government to help states qualify for a new Medicaid provision designed to reward stategovernments for passing groundbreaking anti-fraud legislation. Grassley drafted the new provisionand worked to include it in the Deficit Reduction Act signed into law last month. “This represents a […]
Grassley Asks FDA to Answer Ethicists’ Concerns Over Blood Substitute Study
March 17, 2006 Via Electronic Transmission Dr. Andrew C. von EschenbachActing CommissionerU.S. Food and Drug Administration5600 Fishers LaneRockville, MD 20857 Dear Dr. von Eschenbach: Thank you for scheduling a briefing next Wednesday, March 22, 2006, for myCommittee on Finance (Committee) staff regarding the clinical trial the Food and DrugAdministration (FDA) approved for a blood substitute […]
Grassley Statement at First Tax Conferees Meeting
Tax Reconciliation ConferenceOpening Statement of Chairman GrassleyWednesday, March 15, 2006 Well, we’re finally here. After living through Groundhog Day, three times, we have movedon to the next step in the tax reconciliation process – the first meeting of the conferees from theHouse and the Senate to produce a conference report. To me, the objective of […]
Grassley on the Nomination of an FDA Commissioner
M E M O R A N D U M To: Reporters and EditorsRe: Nomination of a new FDA commissionerDa: Wednesday, March 15, 2006 Sen. Chuck Grassley, chairman of the Committee on Finance, today made the followingcomment on the President’s nomination of acting Food and Drug Administration CommissionerAndrew von Eschenbach as his nominee to become […]
Grassley, Baucus Introduce Bill to Extend, Expand Alternative Energy Tax Breaks
WASHINGTON — Sen. Chuck Grassley, chairman of the Committee on Finance, and Sen.Max Baucus, ranking member, have introduced legislation to extend popular alternative energy taxincentives – such as the wind energy tax credit – for another three years and expand other alternativeenergy tax breaks. “It makes sense to use the tax code to develop alternative […]
Grassley: FDA Needs to Consider Concerns of Human Research Protection Agency in Blood Substitute Study
March 13, 2006 Via Electronic Transmission The Honorable Michael LeavittSecretaryU.S. Department of Health & Human Services200 Independence Avenue, SWWashington, DC 20201Dear Secretary Leavitt: I write you today because you have full authority, as the Secretary of theDepartment of Health and Human Services (Department/HHS), over the Food and DrugAdministration (FDA) and the Office for Human Research […]